Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.

Clinical trial NCT00148551 · UNKNOWN

Trial details

NCT number: NCT00148551
Sponsor: Canadian Retinal Trials Group
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Age-Related Macular Degeneration

Start date: 2004-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.